The Allstate Co. (NYSE:ALL) Shares Purchased by McIlrath & Eck LLC

McIlrath & Eck LLC raised its stake in The Allstate Co. (NYSE:ALLFree Report) by 22.8% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 742 shares of the insurance provider’s stock after acquiring an additional 138 shares during the period. McIlrath & Eck LLC’s holdings in Allstate were worth $141,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. OFI Invest Asset Management purchased a new stake in Allstate during the second quarter valued at about $476,000. Eagle Asset Management Inc. raised its stake in Allstate by 38.0% during the 3rd quarter. Eagle Asset Management Inc. now owns 10,497 shares of the insurance provider’s stock valued at $2,067,000 after purchasing an additional 2,888 shares during the period. Bank of Montreal Can boosted its position in shares of Allstate by 1.7% in the third quarter. Bank of Montreal Can now owns 683,574 shares of the insurance provider’s stock worth $128,758,000 after buying an additional 11,195 shares during the period. Diversified Trust Co grew its holdings in shares of Allstate by 505.3% during the second quarter. Diversified Trust Co now owns 7,923 shares of the insurance provider’s stock valued at $1,265,000 after buying an additional 6,614 shares in the last quarter. Finally, Blueshift Asset Management LLC acquired a new position in Allstate during the third quarter valued at $623,000. 76.47% of the stock is owned by institutional investors.

Allstate Stock Down 2.0 %

NYSE ALL opened at $195.06 on Wednesday. The firm has a 50-day simple moving average of $194.59 and a 200 day simple moving average of $180.71. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The Allstate Co. has a twelve month low of $134.17 and a twelve month high of $209.88. The stock has a market cap of $51.65 billion, a PE ratio of 12.63, a PEG ratio of 1.79 and a beta of 0.50.

Allstate (NYSE:ALLGet Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The company had revenue of $16.63 billion during the quarter, compared to analysts’ expectations of $14.57 billion. During the same quarter in the prior year, the company posted $0.81 EPS. The business’s revenue was up 14.7% on a year-over-year basis. On average, research analysts forecast that The Allstate Co. will post 16.26 EPS for the current year.

Allstate Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be paid a $0.92 dividend. The ex-dividend date is Friday, November 29th. This represents a $3.68 annualized dividend and a dividend yield of 1.89%. Allstate’s dividend payout ratio is currently 23.83%.

Insider Transactions at Allstate

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares in the company, valued at $5,236,922.32. The trade was a 57.06 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.80% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Roth Mkm reissued a “buy” rating and issued a $200.00 price target on shares of Allstate in a research report on Wednesday, August 14th. Raymond James lifted their target price on shares of Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research note on Friday, October 4th. Piper Sandler lifted their price objective on Allstate from $206.00 to $244.00 and gave the company an “overweight” rating in a research report on Tuesday, November 26th. StockNews.com lowered Allstate from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 21st. Finally, Bank of America lifted their price target on Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $217.19.

View Our Latest Stock Analysis on ALL

Allstate Company Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Further Reading

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALLFree Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.